Global Standardization of Clinical Research Data.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 4, p. 18
- By:
- Publication type:
- Article
Works matching IS 10648542 AND DT 2019 AND VI 28 AND IP 4
Results: 11
1
2
Non-Data Scientists: The Evolving Role of Clinical Data Management.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 4, p. 25
- By:
- Publication type:
- Article
3
Framework for FDA's Real-World Evidence Program.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 4, p. 15
- By:
- Publication type:
- Article
4
Optimizing Study Design in Real-World Evidence Generation.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 4, p. 12
- By:
- Publication type:
- Article
5
Q&A.
- Published in:
- 2019
- By:
- Publication type:
- Interview
6
FDA MODERNIZES CONTROLLED CORRESPONDENCE INTERACTIONS WITH INDUSTRY.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 4, p. 7
- By:
- Publication type:
- Article
7
JOINT HTA TALK DOESN'T STOP.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 4, p. 6
- By:
- Publication type:
- Article
8
CHALLENGES IN CONVEYING TRANSLATIONAL RESEARCH MESSAGE.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 4, p. 6
- By:
- Publication type:
- Article
9
SHARPLESS ASSUMES REINS AS AGENCY COMMISSIONER.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 4, p. 4
- By:
- Publication type:
- Article
10
Emerging Biopharma Deserve TLC from CROs.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 4, p. 2
- By:
- Publication type:
- Article
11
FDA SEEKS TO BROADEN CLINICAL TRIAL ELIGIBILITY CRITERIA.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 4, p. 4
- By:
- Publication type:
- Article